E-Mail
IMAGE: Research team from Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam. view more
Credit: AlphaMed Press
Durham, NC Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in
STEM CELLS Translational Medicine.
In a randomized clinical trial at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, researchers investigated the safety and potential therapeutic value of administering bone marrow stromal stem cells to patients with Type 2 diabetes. In each case, the cells were autologous, or taken from the patients own bodies.
Study: Some Type 2 diabetes patients can benefit from bone marrow stem cell transplants
Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in
STEM CELLS Translational Medicine.
In a randomized clinical trial at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, researchers investigated the safety and potential therapeutic value of administering bone marrow stromal stem cells to patients with Type 2 diabetes. In each case, the cells were autologous, or taken from the patients own bodies.
Combining biochemical and topographical cues improves quality of skeletal muscle regeneration
When trauma, illness, or injury causes significant muscle loss, reconstructive procedures for bioengineering functional skeletal muscles can fall short, resulting in permanent impairments.
Finding a synergy in the importance of biochemical signals and topographical cues, researchers from Wake Forest Institute for Regenerative Medicine, Sungkyunkwan University, and Chonnam National University developed an efficient technique for muscle regeneration and functional restoration in injured rats. They describe results from the technique in the journal Applied Physics Reviews, from AIP Publishing.
The group expanded on a method they previously developed using muscle-specific materials derived from an organism s tissues (dECM-MA) to construct bioinks, which are materials used for 3D-printing tissue.
Innovation in a Regulatory Labyrinth
“Regulations don’t always work as planned,” says Tom W. Bell, Professor of Chapman University’s Dale E. Fowler School of Law in
They Say It Can’t Be Done, a documentary [1] highlighting four world-changing technologies and how the people working in those fields view the current regulatory environment. Toward the start of the film, Professor Bell says that when people advocate for regulations, “[t]hey don’t necessarily want more regulations. They want problems fixed.” However, “regulations don’t always work as planned” and can be “like trying to fix a watch with a sledgehammer sometimes.”
Support OneGreenPlanet Being publicly-funded gives us a greater chance to continue providing you with high quality content. Please support us!
Support Us
Disturbing undercover footage from a Spanish research facility that tests on non-human animals came to light in April. Cruelty Free International (CFI) published the footage recorded at Madrid-based Vivotecnia. It showed numerous cases of apparent cruelty, some of which may have fallen foul of the law. EU law dictates that research facilities must choose methods of testing that cause the least amount of pain and suffering. Yet CFI recorded Vivotecnia staff, for example, drawing blood out of the eyes of conscious rats. CFI said the procedure should happen under anesthesia. Previous CFI investigations have shown “barbaric” mistreatment at other labs in the EU too.